title: Atrophie blanche associated with interferon-alfa adjuvant therapy for melanoma: a cutaneous side effect related to the procoagulant activity of interferon?
authors.forename: Leonardo
authors.initials: L
authors.lastname: Bugatti
authors.forename: Giorgio
authors.initials: G
authors.lastname: Filosa
authors.forename: Massimiliano
authors.initials: M
authors.lastname: Nicolini
authors.forename: Alessandra
authors.initials: A
authors.lastname: Filosa
authors.forename: Roberto
authors.initials: R
authors.lastname: Verdolini
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006258:Head and Neck Neoplasms / Q000188:drug therapy*; D006801:Humans; D016898:Interferon-alpha / Q000009:adverse effects* / Q000627:therapeutic use; D008545:Melanoma / Q000188:drug therapy*; D008875:Middle Aged; D017445:Skin Diseases, Vascular / Q000139:chemically induced*
chemical_list: D000970:Antineoplastic Agents; D016898:Interferon-alpha